Presented by George Dippel, President of Deft Research
The Dual Eligible Special Needs Plan (D-SNP) market has grown by half a million members over the last 12 months – with now almost six million individuals! With most Dual eligibles in either straight Medicaid or non-SNP Medicare Advantage Prescription Drug plans (MAPD), the opportunity for D-SNP to grow is significant.
Join Cigna and Deft Research to learn more about our Deft Research study on this topic where we’ll dive into how to inform seniors of the value of moving to D-SNPs, the impact of Highly Integrated D-SNPs (HIDE) / Fully Integrated D-SNPs (FIDE) and monthly Special Enrollment Periods (SEPs), and the influencers of Dual selection.
Date: Tuesday, May 20, 2025
Time: 3:30 p.m. – 4:30 p.m. ET
Location: Virtual event on Webex